AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro

Covered by 2 sourcesPublished 11 days ago

AstraZeneca has entered a deal with AI drug discovery firm Insitro, paying $40 million upfront and potentially up to $1.5 billion if milestones are met, to advance AI-driven therapeutics.

Covered by 2 sources

The Wall Street Journal
ET AI (The Economic Times)

#astrazeneca #biopharmaceuticals #drug-discovery #insitro #virtual-human

AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro

Covered by 2 sources

More in Healthcare

AI-Driven Inventory Optimization As An Operating Model Framework

Healthcare AI Agents Are Here—The Hugging Face Hack Shows Why They Need Guardrails

Machine learning dataset and benchmark for accurate T cell receptor–pHLA binding prediction